Total funding raised Dec 2022
Total Funding Raised - 1.3M€
CancerAppy closed 2022 with €1.3M total raised.
CancerAppy closed 2022 with €1.3M total raised.
We have begun the development of an antibody (CA04 project) against a specific target validated in pancreatic cancer.
CancerAppy has identified two membrane proteins that are upregulated in NSCLC and has patented their use as targets to vectorize compounds against these tumors, or as surrogates for immune activation, to select patients o explore combinations with new immune therapies
CancerAppy closed 2021 with €690K total raised.